Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-23-000006 General Corporate
Debt relative to revenue 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
29.78% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
13.32% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-0.88% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
27.52% · CORE · VALID
Inventory pressure 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
24.01% · OPTIONAL · VALID
Operating margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
6.43% · CORE · VALID
R&D intensity 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.91% · OPTIONAL · VALID
SBC intensity 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.18% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 109.21%
Current 29.78%
Delta -79.42% Capex Intensity Increased
Previous 11.17%
Current 13.32%
Delta 2.15% Cash Generation Decreased
Previous 8.37%
Current -0.88%
Delta -9.24% Growth Increased
Previous 15.42%
Current 27.52%
Delta 12.10% Inventory Pressure Decreased
Previous 73.07%
Current 24.01%
Delta -49.06% Profitability Decreased
Previous 6.90%
Current 6.43%
Delta -0.47% R And D Intensity Decreased
Previous 1.94%
Current 1.91%
Delta -0.03% Sbc Intensity Increased
Previous 1.05%
Current 1.18%
Delta 0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.